Loading...
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study
Four formulations of an investigational tetravalent dengue purified inactivated vaccine, administered as two doses one month (M) apart, were previously shown to be immunogenic and well-tolerated up to M13 of the phase I study NCT01702857. Here, we report results of the follow-up from M14 to year (Y)...
Na minha lista:
| Udgivet i: | Am J Trop Med Hyg |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society of Tropical Medicine and Hygiene
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7204593/ https://ncbi.nlm.nih.gov/pubmed/32124728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.19-0461 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|